Infect Immun 1999, 67:3763–3767.PubMed 65. Rouviere PE, De Las Penas A, Mecsas J, Lu CZ, Rudd KE, Gross CA: rpoE, the gene encoding find more the second heat-shock sigma factor, σE, in Escherichia coli. EMBO J 1995, 14:1032–1042.PubMed 66. Schaeffer LM, McCormack FX, Wu H, Weiss AA: Bordetella pertussis lipopolysaccharide resists the bactericidal effects of pulmonary surfactant protein A. J Immunol 2004, 173:1959–1965.PubMed 67. Datsenko KA, Wanner BL: One-step inactivation of chromosomal genes in Escherichia coli K-12 using PCR products. Proc Natl Acad Sci U S A 2000, 97:6640–6645.PubMedCrossRef 68. Weingart CL, Broitman-Maduro

G, Dean G, Newman S, Peppler M, Weiss AA: Fluorescent labels influence phagocytosis of Bordetella pertussis by human neutrophils. Infect Immun 1999, 67:4264–4267.PubMed 69. Buboltz AM, Nicholson TL, Weyrich LS, Harvill ET: Role of the type III secretion system in a hypervirulent lineage of Bordetella bronchiseptica. Infect Immun 2009, 77:3969–3977.PubMedCrossRef 70. Stibitz S, Carbonetti NH: Hfr mapping of mutations in Bordetella pertussis that define a genetic locus involved in virulence gene regulation. J Bacteriol 1994, 176:7260–7266.PubMed 71. Miller JH: Experiments in molecular genetics. Cold Spring Harbor Laboratory

Press, Cold Spring Harbor, NY; 1972. 72. Crooks GE, Hon G, Chandonia JM, Brenner SE: WebLogo: a sequence logo generator. Genome Res 2004, 14:1188–1190.PubMedCrossRef Selleckchem Selumetinib 73. Goebel EM, Wolfe Doxorubicin cost DN, Elder K, Stibitz S, Harvill ET: O-antigen protects Bordetella parapertussis from complement. Infect Immun 2008, 76:1774–1780.PubMedCrossRef 74. Rodriguez ME, Hellwig SM, Hozbor DF, Leusen J, van der Pol WL, van de Winkel JG: Fc receptor-mediated immunity against Bordetella pertussis. J Immunol 2001, 167:6545–6551.PubMed 75. Rodriguez ME, Van der Pol WL, Van de Winkel JG: Flow cytometry-based phagocytosis assay for sensitive detection of opsonic activity of pneumococcal capsular polysaccharide antibodies in human sera. J Immunol Methods 2001, 252:33–44.PubMedCrossRef 76. Harvill

ET, Preston A, Cotter PA, Allen AG, Maskell DJ, Miller JF: Multiple roles for Bordetella lipopolysaccharide molecules during respiratory tract infection. Infect Immun 2000, 68:6720–6728.PubMedCrossRef 77. Kirimanjeswara GS, Agosto LM, Kennet MJ, Bjornstad ON, Harvill ET: Pertussis toxin inhibits neutrophil recruitment to inhibit antibody-mediated clearance of Bordetella pertussis. J Clin Invest 2005, 115:3594–3601.PubMedCrossRef Authors’ contributions SB and SA conceived and designed the molecular and stress experiments, which were performed by SB. XZ and EH conceived and designed the infection studies, which were performed by XZ. SH performed the cytotoxicity experiments and MR performed the phagocytosis experiments. SB, XZ, EH, and SA wrote the manuscript. All authors have read, contributed to editing, and approved the final manuscript.